```html

Non‑Melanoma Skin Cancer – A Patient‑Friendly Guide

Overview

Non‑melanoma skin cancer (NMSC) is a group of cancers that arise from the skin’s outer layer (the epidermis) but are not melanoma. The two most common types are:

• Basal cell carcinoma (BCC) – originates in basal cells at the bottom of the epidermis.
• Squamous cell carcinoma (SCC) – arises from squamous cells that make up most of the epidermis.

Although each type behaves differently, they share many risk factors and are generally less likely to spread (metastasize) than melanoma.

Who is affected?

Anyone can develop NMSC, but the risk rises sharply with age. In the United States, about 5.4 million cases were diagnosed in 2023 (American Cancer Society). The average age at diagnosis is 65 for BCC and 61 for SCC. NMSC is slightly more common in men than women, likely due to higher occupational sun exposure.

Prevalence worldwide

Europe and Australia report the highest rates, reflecting intense ultraviolet (UV) exposure. According to the World Health Organization (WHO), NMSC accounts for roughly 30% of all new cancer cases globally, making it the most common cancer overall.

Symptoms

Early detection is essential because most NMSC lesions are visible on the skin’s surface. Symptoms can vary by type, but the following list covers the typical presentations.

Basal Cell Carcinoma (BCC)

• Pearly or waxy bump – often pink, tan, or flesh‑colored with a translucent rim.
• Flat, scar‑like lesion – may be white, yellow, or brown, resembling a scar that doesn’t heal.
• Bleeding or crusting – a lesion that bleeds easily after minor trauma.
• Ulceration – a small, open sore that may ooze.
• Visible blood vessels – fine, red lines (telangiectasia) on the surface.

Squamous Cell Carcinoma (SCC)

• Firm, red nodule – may be painless or tender.
• Scaly patch – looks like a persistent sunburn or eczema that won’t clear.
• Open ulcer – a crater‑like sore that may bleed or crust.
• Elevated growth with a raised border – sometimes with a central depression.
• Rapid growth – SCC can enlarge more quickly than BCC.

Symptoms that warrant immediate attention (any type)

• Bleeding that won’t stop.
• Rapid increase in size over weeks.
• Painful or tender lesions.
• Lesion that becomes numb.
• Signs of infection (redness, warmth, pus).

Causes and Risk Factors

Non‑melanoma skin cancer is fundamentally a disease of DNA damage caused by ultraviolet (UV) radiation. Both cumulative sun exposure and intense, intermittent exposure (e.g., blistering sunburns) contribute.

Primary causes

• Ultraviolet‑A (UVA) and Ultraviolet‑B (UVB) radiation – UVB is more energetic and directly damages DNA; UVA penetrates deeper and generates reactive oxygen species.
• Ionizing radiation – therapeutic radiation for other cancers can increase risk in the treated field.
• Human papillomavirus (HPV) infection – especially high‑risk types for SCC on the genitalia and oral mucosa.

Key risk factors

• Fair skin, blond/red hair, blue or green eyes – less melanin offers less natural protection.
• History of sunburns, especially before age 20.
• Lifetime sun exposure – outdoor occupations (construction, farming, lifeguarding) and recreational exposure (skiing, beach activities).
• Previous skin cancer – having one NMSC increases the chance of another.
• Immunosuppression – organ‑transplant recipients, HIV/AIDS, long‑term corticosteroid or biologic therapy.
• Chronic skin injuries – scars, burns, or inflammatory conditions like lichen planus.
• Age – risk climbs sharply after 50.
• Geographic location – higher UV index areas (e.g., Sun Belt of the U.S., Australia, Southern Europe).

Diagnosis

Diagnosing NMSC is usually straightforward because the lesion is visible. However, accurate diagnosis guides appropriate treatment.

Clinical examination

A dermatologist will perform a thorough skin exam, often using a dermatoscope (a magnifying tool with polarized light) to assess patterns of blood vessels and pigmentation.

Biopsy – the gold standard

Several biopsy techniques are employed, depending on lesion size and location:

• Punch biopsy – a small circular blade removes a core of tissue.
• Shave biopsy – a thin slice of the lesion is removed.
• Excisional biopsy – the entire lesion (and a margin of normal skin) is cut out; often both diagnostic and therapeutic.
• Incisional biopsy – a portion of a larger lesion is taken.

The specimen is examined by a pathologist who confirms the type (BCC vs. SCC), depth of invasion, and presence of high‑risk features.

Additional tests (when indicated)

• Imaging (ultrasound, CT, MRI) – if a tumor is large, invades deeper structures, or there is suspicion of spread to lymph nodes.
• Sentinel lymph node biopsy – reserved for high‑risk SCCs >2 cm, poorly differentiated, or with perineural invasion.

Treatment Options

The choice of treatment depends on tumor type, size, location, histologic features, and the patient’s overall health.

Procedural interventions

• Mohs micrographic surgery – the most precise technique; tissue is removed layer‑by‑layer and examined immediately. Offers >99% cure rates for high‑risk sites (nose, eyes, ears).
• Standard excision – surgical removal with predetermined margins (usually 4‑6 mm for BCC, 6‑10 mm for SCC).
• Curettage and electrodessication (C&E) – scraping the tumor followed by cauterization; good for low‑risk, small lesions.
• Laser therapy – CO₂ or erbium‑YAG lasers can vaporize superficial BCCs.
• Topical medications
  • 5‑Fluorouracil (5‑FU) – applied twice daily for 3‑4 weeks; suitable for superficial BCCs and actinic keratoses.
  • Imiquimod – immune‑modulating cream; used for superficial BCC and SCC in situ.
• Photodynamic therapy (PDT) – a photosensitizing agent is applied, then the area is exposed to a specific wavelength of light; effective for superficial BCC and SCC in situ.
• Radiation therapy – external beam radiation for patients who cannot undergo surgery or for tumors in hard‑to‑operate sites.
• Systemic therapy – reserved for advanced or metastatic disease (rare for NMSC). Options include hedgehog pathway inhibitors (vismodegib, sonidegib) for BCC and immune checkpoint inhibitors (cemiplimab, pembrolizumab) for advanced SCC.

Lifestyle and supportive measures

• Protecting the healing wound from sun and infection.
• Regular follow‑up skin checks (every 6‑12 months) to catch new lesions early.
• Smoking cessation – improves wound healing and reduces SCC risk.

Living with Skin Cancer (non‑melanoma)

Most patients are cured with appropriate treatment, but ongoing care is essential.

Daily management tips

• Sun protection – wear broad‑spectrum SPF 30+ sunscreen, reapply every 2 hours, and use protective clothing.
• Self‑skin examinations – perform a monthly head‑to‑toe inspection; use mirrors for hard‑to‑see areas.
• Follow-up appointments – keep scheduled dermatologist visits; report any new or changing lesions promptly.
• Wound care – keep surgical sites clean, use prescribed ointments, and avoid picking at scabs.
• Skin health nutrition – diets rich in antioxidants (berries, leafy greens) may support skin repair.

Psychosocial considerations

A cancer diagnosis can cause anxiety or body‑image concerns, especially for lesions on visible areas (face, hands). Counseling, support groups, and patient education can improve quality of life.

Prevention

Because UV exposure is the primary modifiable factor, prevention focuses on limiting UV damage.

Sun‑safe habits

• Seek shade between 10 am and 4 pm when UV rays are strongest.
• Wear a wide‑brimmed hat, UV‑protective sunglasses, and UPF‑rated clothing.
• Apply sunscreen 15‑30 minutes before going outdoors; use at least 2 mg/cm² (about a nickel‑size dollop for the face).
• Reapply after swimming, sweating, or toweling off.
• Avoid tanning beds; artificial UV sources increase NMSC risk by up to 75% (CDC).

Regular skin screening

Adults ≥ 40 years should have a professional skin exam every 1‑2 years, or sooner if they have risk factors.

Medication safety

Photosensitizing drugs (e.g., certain antibiotics, retinoids, antihistamines) can increase UV damage. Discuss alternative options with your physician if you require long‑term use.

Complications

While most NMSCs are curable, untreated lesions can lead to serious outcomes.

Potential complications

• Local invasion – BCC can erode bone or cartilage (e.g., nasal ala, orbital rim); SCC can infiltrate muscle, nerves, or deeper subcutaneous tissue.
• Disfigurement – surgical removal in cosmetically sensitive sites may cause scarring.
• Metastasis – rare for BCC (<0.1%); SCC has a 2‑5% chance of spreading to lymph nodes, lungs, or other organs, especially when high‑risk features are present.
• Functional impairment – lesions near eyes, ears, or mouth can affect vision, hearing, or speech if they grow unchecked.
• Psychological distress – chronic skin changes can lead to depression or anxiety.

When to Seek Emergency Care

References

• American Cancer Society. Basal Cell Carcinoma. 2023.
• Cleveland Clinic. Squamous Cell Carcinoma. Updated 2024.
• Centers for Disease Control and Prevention (CDC). Skin Cancer Prevention. 2022.
• Mayo Clinic. Basal cell carcinoma. Reviewed 2024.
• World Health Organization. Ultraviolet (UV) radiation. 2023.
• National Cancer Institute. Skin Cancer Treatment (PDQ®)–Patient Version. Updated 2024.

```